Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:      
Net income $ 756,015 $ 794,488 $ 212,300
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 92,133 86,044 87,348
Asset impairment charges 2,878 10,568 15,149
Net gain on sale of real estate assets 0 (1,372) (2,984)
Non-cash stock-based compensation expense 78,835 81,430 85,982
Provision for doubtful accounts 0 0 (2,888)
Net gain on sale of marketable securities and other investments (637) (2,479) (5,077)
Deferred income taxes 193,412 64,736 (19,865)
Tax charge from equity awards 0 0 (5,133)
Excess tax benefit from equity awards 0 (71) 0
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business combinations:      
Increase in accounts receivable, net (113,922) (128,219) (220,857)
Increase in inventories (93,145) (170,141) (27,715)
Decrease (increase) in other assets 58,041 (56,743) 102,033
Increase (decrease) in accounts payable (3,732) 34,259 44,381
Increase (decrease) in deferred system profit (45,121) (12,425) 108,943
Increase in other liabilities 16,860 123,091 76,183
Net cash provided by operating activities 941,617 823,166 447,800
Cash flows from investing activities:      
Acquisitions of businesses, net of cash received 0 0 (1,500)
Capital expenditures, net (57,596) (51,151) (30,202)
Proceeds from sale of assets 2,228 18,185 5,878
Purchase of available-for-sale securities (1,522,424) (1,142,491) (1,080,412)
Proceeds from sale and maturity of available-for-sale securities 1,046,665 795,762 854,970
Purchase of trading securities (55,906) (63,005) (77,295)
Proceeds from sale of trading securities 58,142 83,190 100,597
Net cash used in investing activities (528,891) (359,510) (227,964)
Cash flows from financing activities:      
Issuance of common stock 163,569 124,573 35,867
Tax withholding payments related to vested and released restricted stock units (30,247) (22,557) (13,514)
Common stock repurchases (263,864) (234,844) (136,275)
Excess tax benefit from equity awards 0 71 0
Payment of dividends to stockholders (233,561) (167,398) (102,409)
Net cash used in financing activities (364,103) (300,155) (216,331)
Effect of exchange rate changes on cash and cash equivalents (8,658) 17,910 1,446
Net increase in cash and cash equivalents 39,965 181,411 4,951
Cash and cash equivalents at beginning of period 711,329 529,918 524,967
Cash and cash equivalents at end of period 751,294 711,329 529,918
Supplemental cash flow disclosures:      
Income taxes paid (refunds received), net 20,018 262,086 (13,989)
Interest paid $ 54,523 $ 52,819 $ 52,438